Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Argus Health
Boehringer Ingelheim
Johnson and Johnson
QuintilesIMS
Queensland Health
UBS
Fuji
Cantor Fitzgerald
Mallinckrodt

Generated: December 11, 2017

DrugPatentWatch Database Preview

Lidocaine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for lidocaine hydrochloride and what is the scope of lidocaine hydrochloride freedom to operate?

Lidocaine hydrochloride
is the generic ingredient in thirty-five branded drugs marketed by Akorn, Carlisle, Abbott, Abraxis Pharm, Aurobindo Pharma Ltd, Bel Mar, Belmora Llc, Dell Labs, Elkins Sinn, Gd Searle Llc, Hospira, Intl Medication, Luitpold, Luitpold Pharms Inc, Lyphomed, Miles, Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Baxter Hlthcare, B Braun, Fresenius Kabi Usa, Pharmaton, Meridian Medcl Techn, Astrazeneca, Dentsply Pharm, Bionpharma Inc, Sagent Pharms, G And W Labs Inc, Watson Labs Inc, Oak Pharms, Hi Tech Pharma, Wockhardt, Actavis Mid Atlantic, Vintage, Kendall Il, Paco, Teligent Pharma Inc, Powder Pharms, and Pfizer, and is included in ninety-nine NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Lidocaine hydrochloride has twenty-three patent family members in twelve countries.

There are twenty-nine drug master file entries for lidocaine hydrochloride. Forty-six suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Belmora LlcLIDOCAINE HYDROCHLORIDElidocaine hydrochlorideINJECTABLE;INJECTION080504-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINElidocaine hydrochlorideINJECTABLE;INJECTION006488-008Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
PacoLIDOCAINE HYDROCHLORIDElidocaine hydrochlorideSOLUTION;TOPICAL089688-001Jun 30, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINE 1.5% W/ DEXTROSE 7.5%lidocaine hydrochlorideINJECTABLE;SPINAL016297-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntLIDOCAINE HYDROCHLORIDElidocaine hydrochlorideSOLUTION;TOPICAL088803-001Apr 3, 1985ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdLIDOCAINE HYDROCHLORIDE PRESERVATIVE FREElidocaine hydrochlorideINJECTABLE;INJECTION203040-001Mar 14, 2013APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINElidocaine hydrochlorideINJECTABLE;INJECTION006488-002Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Oak PharmsXYLOCAINElidocaine hydrochlorideJELLY;TOPICAL008816-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
HospiraLIDOCAINE HYDROCHLORIDElidocaine hydrochlorideINJECTABLE;INJECTION088331-001May 17, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaXYLOCAINE VISCOUSlidocaine hydrochlorideSOLUTION;ORAL009470-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
Powder PharmsZINGOlidocaine hydrochlorideSYSTEM;INTRADERMAL022114-001Aug 16, 2007► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: lidocaine hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,044,546Particle cassettes and processes therefor► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: lidocaine hydrochloride

Country Document Number Estimated Expiration
South Korea20160141717► Subscribe
European Patent Office2043601► Subscribe
China106163500► Subscribe
Australia1935997► Subscribe
European Patent Office3110404► Subscribe
Japan3602543► Subscribe
Singapore11201606034W► Subscribe
Japan2017524384► Subscribe
World Intellectual Property Organization (WIPO)2008014036► Subscribe
United Kingdom0708758► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Julphar
UBS
Chinese Patent Office
Fish and Richardson
QuintilesIMS
Harvard Business School
Johnson and Johnson
Citi
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot